Atara Biotherapeutics Inc... (ATRA)
NASDAQ: ATRA
· Real-Time Price · USD
12.24
0.52 (4.44%)
At close: Aug 15, 2025, 3:59 PM
12.74
4.08%
After-hours: Aug 15, 2025, 07:47 PM EDT
Atara Biotherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 2.39M | 38.01M | -12.69M | -21.91M | -19.05M | -31.75M | -60.45M | -69.8M | -71.11M | -74.77M | -74.57M | -84.09M | 18.47M | -88.11M | -93.35M | -84.66M | -83.79M | -78.33M |
Depreciation & Amortization | 494K | 1.79M | 1.1M | 1.2M | 1.33M | 1.39M | 1.21M | 1.21M | 1.2M | 1.21M | 1.25M | 1.37M | 1.44M | 1.59M | 2.49M | 2.32M | 2.32M | 2.22M |
Stock-Based Compensation | 2.8M | 4.21M | 5.85M | 6.42M | 6.34M | 8.4M | 9.93M | 11.14M | 12.55M | 11.76M | 11.36M | 14.02M | 14.12M | 14.34M | 14.03M | 13.76M | 13.81M | 12.27M |
Other Working Capital | 82.39M | -82.39M | -24.32M | 3.82M | -36.53M | -2.8M | 32.59M | -2.1M | 4.62M | -14.63M | 48.14M | 1.7M | -51.01M | -9.21M | 44.41M | 4.31M | -1.33M | -1.61M |
Other Non-Cash Items | -95.11M | 9.96M | 3.68M | 3.74M | 4.12M | 24.19M | 58.4M | 4.34M | 4.22M | 3.81M | 2.94M | 2.94M | 2.77M | 1.13M | 696K | 541K | 404K | 394K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -52.21M | -214K | -755K | n/a | n/a | n/a | n/a | n/a | 539K | 400K | 491K | 360K |
Change in Working Capital | 82.11M | -82.11M | -22.41M | 6.56M | -3.38M | -11.73M | -7.28M | 1.97M | 1.09M | 19.55M | 2.13M | 707K | -50.83M | -13.48M | 41.33M | 8.67M | 5.2M | -2.61M |
Operating Cash Flow | -7.32M | -28.14M | -24.47M | -3.99M | -10.64M | -29.61M | -50.41M | -51.35M | -52.8M | -38.43M | -56.88M | -65.06M | -63.96M | -84.53M | -34.27M | -58.98M | -61.58M | -65.7M |
Capital Expenditures | n/a | n/a | -90K | n/a | -29K | -127K | -44K | -281K | -499K | -399K | -37K | -132K | -1.42M | -2.6M | -2.47M | -3.86M | -2.06M | -2.2M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -40.36M | 25K | -49.98M | 5.61M | -51.26M | -59.83M | 94.77M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -5.42M | n/a | n/a | -19.66M | n/a | n/a | -1K | -25K | -15.74M | -67.9M | 575K | -16.07M | -138.66M | -26.43M | -76.38M | -65.89M | -64.81M | -94.06M |
Sales Maturities Of Investments | n/a | 17.2M | 3.47M | 3M | 7.22M | 14.84M | 9.99M | 70.7M | 65.72M | 62.3M | 50.68M | 75.9M | 77.14M | 89.25M | 54.52M | 70.94M | 98.76M | 109.75M |
Other Investing Acitivies | 349K | n/a | n/a | n/a | n/a | 14.84M | 40.36M | 25K | 49.98M | -5.61M | 51.26M | 59.83M | 33.24M | 62.82M | -21.86M | 5.05M | 33.95M | 15.7M |
Investing Cash Flow | -5.07M | 17.2M | 3.38M | -16.66M | 7.2M | 14.72M | 9.94M | 70.45M | 49.48M | -6.01M | 51.22M | 59.7M | 31.83M | 60.22M | -24.32M | 1.19M | 31.89M | 13.5M |
Debt Repayment | n/a | -250K | -235K | -197K | -233K | -227K | -215K | -208K | -212K | -312K | -122K | -206K | -126K | -64K | -62K | -62K | -64K | -66K |
Common Stock Repurchased | n/a | n/a | n/a | 6K | n/a | n/a | n/a | n/a | -1K | n/a | n/a | -4K | -3K | n/a | n/a | n/a | -13K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 15.3M | n/a | 74.89M | -14.82M | 112K | -6K | 181K | n/a | 684K | -93K | 432K | -8K | 1.29M | -624K | 1.57M | 842K | 2.52M | 501K |
Financial Cash Flow | 15.3M | -250K | -328K | 35.79M | -324K | 24.14M | 1.51M | -208K | 471K | 235K | 32.29M | -214K | 1.16M | 19.85M | 51.47M | 47.14M | 2.45M | 2.89M |
Net Cash Flow | 2.92M | -11.19M | -21.42M | 15.14M | -3.77M | 9.25M | -38.95M | 18.89M | -2.84M | -44.2M | 26.63M | -5.57M | -30.98M | -4.46M | -7.13M | -10.65M | -27.24M | -49.31M |
Free Cash Flow | -7.32M | -28.14M | -24.56M | -3.99M | -10.67M | -29.74M | -50.45M | -51.63M | -53.3M | -38.83M | -56.92M | -65.19M | -65.38M | -87.13M | -36.73M | -62.83M | -63.64M | -67.89M |